A. Madeja and
E. Zych*ab
aFaculty of Chemistry, University of Wroclaw, 14 F. Joliot-Curie Street, 50-383 Wroclaw, Poland. E-mail: Eugeniusz.zych@chem.uni.wroc.pl
bWroclaw Research Centre EIT+, 147 Stablowicka Street, 54-066 Wroclaw, Poland
First published on 20th November 2015
Phase-pure orthorhombic and monoclinic Sr2SiO4 and its Ce3+- or Eu2+-activated versions were synthesized using H3BO3 or SrCl2 fluxes. The effects of the type of dopant and its concentration, as well as the type of flux on the crystallization were revealed and discussed. The luminescence properties of the phase-pure Ce3+- or Eu2+-activated powders were characterized both at 30 K and 300 K. The presence of two luminescent sites was proved in both types of structures and in the case of both activators, and their characteristic excitation and emission spectra were presented. Energy transfer from ions emitting at higher energies to those giving luminescence at lower energies was shown to take place in both polymorphs and in the case of each of the dopants. Eu2+ emissions of both sites in both structures were located fully in the visible part of the spectrum, while part of the Ce3+ luminescence occurred in the long-wavelength UV. Room-temperature radioluminescence spectra showed that only the site emitting at longer wavelengths, in both structures and for both dopants, is active in the scintillation process. For the first time, for both dopants, luminescence from the two sites in both polymorphs of Sr2SrO4 has been spectroscopically characterized at 30 K and at room temperature.
It is already about thirty years since the first reports on the crystal structure of Sr2SiO4 were published by Catti and his co-workers.27–31 The existence of two polymorphs, orthorhombic α′-Sr2SiO4 and monoclinic β-Sr2SiO4, together with some data on their phase transitions, were presented then.
The orthorhombic α′-form crystallizes in the Pmnb space group, while the monoclinic β-form crystallizes in the P121/n1 space group. Most studies have proved that getting phase-pure Sr2SiO4, undoped or activated, is a difficult task, and till now there are no known clear rules governing the phase equilibrium in Sr2SiO4. For example, replacing some Sr2+ ions with either larger Ba2+ or smaller Ca2+ seemed to stabilize the orthorhombic structure.1,14,23,29,30 It was suggested that the stabilization is due to changes in the lengths of the metal–oxygen bonds.1,5,14,16,23,29,30
Consequently, in most of the published papers on the luminescence properties of Sr2SiO4-based phosphors, mixtures of both phases were obtained and investigated.4,5,12,14,25 Nevertheless, it was reported that pure orthorhombic13,15–20,22,24,26 or monoclinic phases9,11,18,21 could be synthesized when Sr2SiO4 was doped with Eu2+, Eu3+, Dy3+ or Tb3+ ions. Thus, it appeared that just a small amount of the impurity ions was able to stabilize one of the two structures. It was indicated that getting the orthorhombic α′-form is possible when more than 1 mol% of dopants with ionic radii similar to that of the Sr2+ ion are used. In fact, the problem of getting phase-pure powders was so difficult to solve that products with only a residual impurity phase were sometimes claimed to be phase-pure. A close examination of the presented XRD patterns proves, however, the presence of a small amount of the other polymorph.1,2,6,8,10,23,25
The two structures, orthorhombic α′-Sr2SiO4 and monoclinic β-Sr2SiO4, present some similarities important for the spectroscopic properties of the incorporated activators. Firstly, in each of them, Sr2+ ions occupy two different symmetry sites. Secondly, the coordination numbers (CN) of the metal sites in both phases are the same: CN = 10 (Sr(1)) and CN = 9 (Sr(2)). In Fig. 1 we present unit cells of both structures together with the local arrangements of the two Sr sites in each of them. In Table 1 we list the Sr–O and Sr–Sr distances in the orthorhombic α′-Sr2SiO4 and monoclinic β-Sr2SiO4 which might be helpful in understanding the spectroscopic properties of these compositions when doped with Ce3+ or Eu2+ ions. We note that both the shortest and average Sr(1)–O and Sr(2)–O distances in the two structures are similar. This, combined with the identical CNs, may justify quite similar energetic positions of at least the lowest (emitting) 5d levels of Ce3+ or Eu2+ dopants occupying analogous – Sr(1) or Sr(2) – sites in the two polymorphs. However, since the 5d orbitals are the most outside located and are not screened from the influence of the surroundings, even the small changes in the distances should exert measurable effects on the energetic positions of the orbitals. In contrast, when we compare the shortest and average distances of Sr(1)–O and Sr(2)–O within the same polymorph, we see that they differ quite significantly (see Table 1). Thus we can expect that within the same structure, both in the case of Ce3+ and Eu2+, the energetic positions of the emitting states should differ quite profoundly. The Sr(1)–Sr(2) distances are short, which obviously favours energy exchange between dopants occupying different sites in either of the two hosts. We shall see that such energy transfer is indeed efficient in both hosts and for both activators.
![]() | ||
| Fig. 1 Unit cells of both (a) orthorhombic and (b) monoclinic Sr2SiO4 structures, together with the local arrangements of the two Sr sites in each of them. | ||
27
| α′-Sr2SiO4 | β-Sr2SiO4 | |
|---|---|---|
| Sr(1)–O(1I) | 2.386(7) | 2.37(1) |
| Sr(1)–O(2) | 2.771(7) | 2.801(8) |
| Sr(1)–O(2,2III) | 2.842(6) (×2) | 2.57(1) |
| Sr(1)–O(2,2II) | 3.11(1) | |
| Sr(1)–O(3) | 3.021(6) (×2) | 2.764(8) |
| Sr(1)–O(4) | 3.199(8) | |
| Sr(1)–O(3,2II) | 2.846(6) (×2) | 2.63(1) |
| Sr(1)–O(4,2II) | 2.93(1) | |
| Sr(1)–O(3,4V) | 2.972(7) (×2) | 3.35(1) |
| Sr(1)–O(4,4V) | 2.78(1) | |
| Average | 2.852 | 2.850 |
![]() |
||
| Sr(2)–O(1I) | 2.593(8) | 2.62(1) |
| Sr(2)–O(2I) | 2.622(7) | 2.651(8) |
| Sr(2)–O(2,4I) | 2.622(7) | 2.624(9) |
| Sr(2)–O(1,2III) | 3.105(3) (×2) | 3.40(1) |
| Sr(2)–O(1,2II) | 2.78(1) | |
| Sr(2)–O(3,2II) | 2.609(6) (×2) | 2.694(8) |
| Sr(2)–O(4,2III) | 2.565(8) | |
| Sr(2)–O(3,3VI) | 2.507(6) (×2) | 2.527(9) |
| Sr(2)–O(4,3VIII) | 2.519(9) | |
| Average | 2.698 | 2.709 |
![]() |
||
| Sr(1)–Sr(1) | 3.019 | 4.891 |
| 3.796 | 5.683 | |
| 3.951 | 3.866 | |
| 4.867 | 3.957 | |
| 5.811 | 5.851 | |
| 5.796 | ||
| Sr(1)–Sr(2) | 3.897 | 3.705 |
| 3.634 | 3.622 | |
| 3.894 | 3.746 | |
| 3.757 | 4.083 | |
| 3.874 | ||
| Sr(2)–Sr(2) | 3.689 | 3.690 |
| 4.799 | 4.558 | |
| 5.682 | 5.663 | |
In this paper we shall show that it is possible to synthesize phase-pure Sr2SiO4:Ce and Sr2SiO4:Eu (both orthorhombic and monoclinic) phosphors using two different fluxes, SrCl2 and H3BO3. It will be proved that by applying H3BO3 and using either of the dopants, Ce or Eu, the powders crystallize in the orthorhombic α′-phase. However, a SrCl2 flux leads to the monoclinic β-phase in the case of Sr2SiO4:Ce powders or when not more than 0.1 mol% of Eu is doped. On the other hand, using 1 mol% of Eu causes crystallization in the orthorhombic α′-phase. Photo- and radioluminescence properties of the phase pure phosphors in the 30–300 K range of temperatures will also be presented.
| Processing parameters | Sr2SiO4:Ce | |||||
|---|---|---|---|---|---|---|
| Temperature | Time | Atmosphere | Flux (wt%) | Dopant concentration (mol%) | Structure of the product | Composition number |
| 1200 °C | 4 h | Air | 1%, 5%, 10% SrCl2 | 1% | Mixture of both phases | SCe1, SCe4, SCe7 |
| 15%, 50% SrCl2 | 1% | Monoclinic | SCe10, SCe13 | |||
| 50% SrCl2 | 0.1% | Monoclinic | SCe17 | |||
| 1% H3BO3 | 0.1%, 1%, 1.5% | Mixture of both phases | SCe21, SCe24, SCe27 | |||
| 1300 °C | 4 h | Air | 1%, 5%, 10% SrCl2 | 1% | Mixture of both phases | SCe2, SCe5, SCe8 |
| 15% SrCl2 | 1% | Monoclinic | SCe11 | |||
| 50% SrCl2 | 0.1% | Monoclinic | SCe18 | |||
| 1% H3BO3 | 0.1% | Mixture of both phases | SCe22 | |||
| 1% H3BO3 | 1%, 1.5% | Orthorhombic | SCe25, SCe28 | |||
| 1300 °C + cooling to 850 °C, 3 °C min−1 | 4 h | Air | 50% SrCl2 | 0.1%, 1% | Monoclinic | SCe19, SCe14 |
| 1400 °C | 4 h | Air | 1%, 5%, 10% SrCl2 | 1% | Mixture of both phases | SCe3, SCe6, SCe9 |
| 15%, 50% SrCl2 | 1% | Monoclinic | SCe12, SCe15 | |||
| 50% SrCl2 | 0.1% | Monoclinic | SCe20 | |||
| 1% H3BO3 | 0.1% | Mixture of both phases | SCe23 | |||
| 1% H3BO3 | 1%, 1.5% | Orthorhombic | SCe26, SCe29 | |||
| 1400 °C + cooling to 850 °C, 3 °C min−1 | 4 h | Air | 15% SrCl2 | 1% | Monoclinic | SCe16 |
| Processing parameters | Sr2SiO4:Eu | |||||
|---|---|---|---|---|---|---|
| Temperature | Time | Atmosphere | Flux (wt%) | Dopant concentration (mol%) | Structure of the product | Composition number |
| 1300 °C | 4 h | Air | 15% SrCl2 | 1% | Orthorhombic | SEu3 |
| 1400 °C | 4 h | Air | 15% SrCl2 | 1% | Orthorhombic | SEu4 |
| 1% H3BO3 | 1% | Orthorhombic | SEu11 | |||
| 1400 °C | 4 h | Active carbon | 15% SrCl2 | 1% | Orthorhombic | SEu7 |
| (1) 1400 °C, (2) 1400 °C | 4 h | Air, H2(5%)/N2(95%), H2(25%)/N2(75%) | 15% SrCl2 | 1% | Orthorhombic | SEu5, SEu6 |
| (1) 1400 °C, (2) 650 °C | 4 h, 0.5 h | Active carbon air | 15% SrCl2 | 0.1% | Monoclinic | SEu1 |
| 0.5% | Mixture of both phases | SEu2 | ||||
| 1%, 2% | Orthorhombic | SEu8, SEu9 | ||||
| 1% H3BO3 | 0.1% | Mixture of both phases | SEu10 | |||
| 1% | Orthorhombic | SEu12 | ||||
To monitor the completeness of the reaction and phase purity of the products, X-ray diffraction (XRD) patterns were measured with a Bruker D8 Advance diffractometer equipped with a Cu lamp. The measurements were taken in the range of 2θ = 10–90° with 2θ = 0.032° steps.
The morphology of the powders was revealed by means of scanning electron microscopy (SEM) imaging with a Hitachi S-3400N instrument, equipped with an energy-dispersive X-ray spectroscopy (EDX) EDAX analyser.
Room-temperature radioluminescence (RL) spectra were recorded using white X-rays from a Cu X-ray tube working under the voltage of 40 kV and the current of 10 mA. The emission photons were collected with a 74-UV lens connected to a QP600-2-SR-BX waveguide, which transferred the luminescent light to an Ocean Optics HR2000CG-UV-NIR spectrometer, controlled by the dedicated software SpectraSuit. The RL light yields of our materials were compared with the results for a commercial Lu2SiO5:Ce (LSO) powder kindly offered by Phosphor Technology Ltd.
(I) Undoped Sr2SiO4 powders obtained from synthesis with either SrCl2 or H3BO3 flux crystallize in the monoclinic system (see Fig. 2a).
(II) Sr2SiO4:Ce obtained using more than 10 wt% of SrCl2 flux crystallizes in the monoclinic structure. A lower content of the flux leads to a mixture of α′- and β-phases.
(III) Sr2SiO4:Ce obtained using a H3BO3 flux tends to crystallize in the orthorhombic structure, but phase-pure powder is formed only when the Ce content is not lower than 1 mol% (with respect to Sr) and the preparation temperature is not lower than 1300 °C. Processing below 1300 °C and/or using less than 1 mol% of Ce leads to a powder composed of a mixture of both phases.
(IV) Sr2SiO4 doped with 0.1 mol% Eu synthesized with the SrCl2 flux crystallizes in the monoclinic structure, while a 0.5 mol% concentration of Eu leads to a mixture of α′- and β-phases. However, higher concentrations give the orthorhombic structure.
(V) Powders containing 0.1 mol% of Eu and made with a H3BO3 flux contain a mixture of both phases.
(VI) Sr2SiO4:Eu powders crystallize in purely the orthorhombic phase when the Eu content is not lower than 1 mol%, regardless of whether a SrCl2 or a H3BO3 flux is used.
Thus, using the two fluxes, Ce-activated Sr2SiO4 may be crystallized as a phase-pure, either orthorhombic or monoclinic, phosphor. When Eu is used as the dopant, both phases can be obtained, but crystallization depends on the Eu concentration.
![]() | ||
| Fig. 4 Morphology of Sr2SiO4:Eu (1 mol%) (orthorhombic phase), prepared at 1400 °C for 4 h in syntheses with (a) 15 wt% SrCl2 (SEu8) and (b) 1 wt% H3BO3 (SEu12). | ||
Sr2SiO4:1 mol% Eu crystallized in the orthorhombic phase irrespective of the flux used in the synthesis. Yet the morphology differed in both cases, as is presented in Fig. 4. Synthesis using the SrCl2 flux gave slightly elongated grains reaching sizes of about 30 × 50 μm (see Fig. 4a). The H3BO3 flux led to powders with a much less uniform morphology, very similar to what was presented in Fig. 3c for the Ce-activated orthorhombic phase. Hence, it appears that the morphology of the Sr2SiO4 is defined by the flux used in the synthesis and is actually hardly affected by the type of structure in which the powder crystallizes. The monoclinic Sr2SiO4:Ce (Fig. 3a and b) and orthorhombic Sr2SiO4:Eu powders (Fig. 4a) consisted of particles quite similar in shape and size, although for the latter the small-grains fraction was practically absent even if the cooling rate was not controlled.
The average size of particles was smaller when boric acid was used as the flux. This might have resulted from the amount of this flux being very small (1 wt%) compared to SrCl2 (15–50 wt%), although in such a small concentration H3BO3 could effectively mediate the chemical reaction but hardly affected the crystal growth. We observed a similar effect in making Lu2O3:Eu, in which the particles’ growth was strongly dependent on the amount of Li2SO4 flux used in the process.32
Nevertheless, at room temperature the emission bands of the orthorhombic Sr2SiO4:1 mol% Ce (Fig. 5a and b) appear at wavelengths longer by about 5–10 nm, and a similar red shift is seen in the position of the lowest-energy excitation bands compared to those of the monoclinic phase. Bearing in mind that the average Sr–O distances in both structures are indeed very similar (see Table 1), the very small difference in the RT luminescence band positions is quite realistic, in fact.
Low-temperature PL and PLE spectra of both phases of Sr2SiO4:Ce are presented in Fig. 6. Results related to the orthorhombic α′-phase are given in Fig. 6a and b (sample SCe26), and those connected with the monoclinic β-phase are presented in Fig. 6c and d (sample SCe15). Compared to the analogous RT spectra, the presence of two Ce3+ emitting centres is now evident in both phases, while analogous RT spectra did not give a clear answer to that question (see Fig. 5). Comparison of the RT and low-temperature results makes it apparent that Ce(Sr1) → Ce(Sr2) energy transfer occurs even at 30 K. It is thus not surprising that at RT almost all emitted radiation comes from the Ce(Sr2) centre in both phases. For both phases, in the PLE spectra of the long-wavelength emissions (Ce(Sr2)), the bands characteristic for the Ce(Sr1) centre emitting at shorter wavelengths are obviously present, confirming the Ce(Sr1) → Ce(Sr2) energy transfer. In the RT PLE spectra, this effect was more profound, as expected. This is most clearly seen at around 310 and 335 nm for the orthorhombic α′-phase (Fig. 6a) and at around 310 nm for the monoclinic β-phase (Fig. 6c). Accordingly, appropriately selected excitation wavelengths allowed the separation of the site-characteristic luminescent bands pretty fairly only at low temperature. This was more successful in the case of the monoclinic β-phase (Fig. 6d) than for the orthorhombic α′-phase (Fig. 6b), altogether, according to the data presented in Fig. 6, the presence of two Ce3+ emitting centres is obvious in both structures. On the other hand, since the positions of the electronic levels of the Ce(Sr1) and Ce(Sr2) centres favour energy transfer by the Förster mechanism33 (which is proved by the excitation spectra), it is not surprising that a complete spectroscopic separation of the site-related emission and excitation bands was not achieved.
Excitation and emission spectra of the orthorhombic Sr2SiO4:1 mol% Eu are presented in Fig. 7a and b (sample SEu8), and of the monoclinic phase in Fig. 7c and d (0.1 mol% Eu, sample SEu1). Regardless of the crystallographic phase, for the Eu-activated composition, it is evident already at RT that the dopant occupies at least two distinct symmetry sites with significantly different positions of the emitting and excitation bands. Excitation at around 450 nm gave rise to a characteristic broad-band luminescence peaking at around 590 nm and 550 nm for the α′ and β-forms, respectively (see Fig. 7b and d). In the case of the orthorhombic α′-phase, excitation at around 290–330 nm produces a structured luminescent band in which the 590 nm component is accompanied by another, more energetic emission, peaking at around 480–500 nm (Fig. 7b). The latter component is less significant in intensity, most probably due to the anticipated Eu(Sr1) → Eu(Sr2) energy transfer. We observed a greater change with excitation wavelength in powders which crystallized in the monoclinic β-phase. Excitation at around 275–330 nm produces an emission band with a maximum at around 470 nm, accompanied by a component with a maximum at around 540–550 nm. Excitation at 250 nm favours luminescence peaking at around 540 nm, and this latter band is observed exclusively upon 450 nm irradiation (Fig. 7d).
![]() | ||
| Fig. 7 RT excitation and emission spectra of powders: (a) and (b) orthorhombic Sr2SiO4:1 mol% Eu (SEu8); (c) and (d) monoclinic Sr2SiO4:0.1 mol% Eu (SEu1). | ||
Comparing the emission spectra of the 1 mol% orthorhombic (Fig. 7b) and 0.1 mol% monoclinic (Fig. 7d) samples, we see that in the former the energy more efficiently leaks to the Eu2+ ions emitting at longer wavelengths. This points to a more efficient Eu(Sr1) → Eu(Sr2) energy transfer in the 1 mol% orthorhombic powder. This is reasonable, as in both phases the short-wavelength emission band overlaps partially with absorption (excitation) of the long-wavelength emitting centre. Thus energy from the more energetic luminescence centre of the Eu(Sr1) may be nonradiatively drained by the Förster mechanism32 to the energetically lower levels of the Eu(Sr2). Thus, the RT experiments already prove that in both phases Eu2+ ions occupy the two available sites and give rise to distinct, though partially overlapping, emission bands. Below, we shall present low-temperature experiments from which the presence of Eu2+ ions in different sites will be even more convincing.
Low-temperature PLE and PL spectra of the Sr2SiO4:1 mol% Eu orthorhombic α′-phase (Fig. 8a and b – sample SEu8) and Sr2SiO4:0.1 mol% Eu monoclinic β-phase (Fig. 8c and d – sample SEu1) allowed a clearer exposure of the two emitting centres in each phase. The α′-phase gave two clearly separated emitting bands peaking at 470 nm, Eu(Sr1), and 550 nm, Eu(Sr2), upon 310 nm excitation. The former became relatively weaker with increasing excitation wavelength. When the excitation was performed at 400 nm or at yet lower energies, only the longer-wavelength emission band (550 nm) was present. The low-temperature PLE spectra show that the most efficient excitation of the long-wavelength emission (peaking at 550 nm) occurred at around 430 nm, while the short-wavelength luminescence (470 nm) was most effectively excited at around 330 nm. In the excitation spectrum of the 550 nm luminescence (Eu(Sr2)), the bands characteristic for the other centre (Eu(Sr1)) are clearly present, though they have low intensities. It is clear that some Eu(Sr1) → Eu(Sr2) energy transfer occurs.
![]() | ||
| Fig. 8 Low-temperature excitation and emission spectra of the following powders: (a) and (b) orthorhombic Sr2SiO4:1 mol% Eu (SEu8); (c) and (d) monoclinic Sr2SiO4:0.1 mol% Eu (SEu1). | ||
Therefore, it is not possible to exclusively record luminescence of the high energy, Eu(Sr1), centre. A long-wavelength excitation (460 nm) produced a single band emission (Fig. 8b, red line) which was slightly red-shifted and peaked at around 600 nm. A closer inspection reveals that its shape was slightly distorted, suggesting a superposition of two components. This is surprising as the host does not offer a third site. A possibility of a small admixture of the β-phase (not recordable by XRD) cannot explain this effect, as the β-phase does not produce such a long-wavelength luminescence, as we shall see shortly. An excitation spectrum of the emission monitored at 620 nm indeed shows a noticeable long-wavelength broadening compared to the PLE of the 550 nm emission (see Fig. 8a). It is possible that certain Eu(Sr2) centres experience some structural distortion. Yet details of this effect remain unclear at present. Note that the presented spectra are normalized to the same height. In fact, the long-wavelength emission is much less intense than the two regular ones peaking at around 475 nm and 550–560 nm.
In the case of the monoclinic β-phase (Sr2SiO4:0.1 mol% Eu, see Fig. 8c and d), quite a similar behaviour was observed at 30 K. Two emission bands peaking at 470 nm (Eu(Sr1)) and 545 nm (Eu(Sr2)) are clearly seen. Again, only the one at longer wavelength can be generated separately. The more energetic emission is always accompanied by the less energetic one, due to the unavoidable energy transmission down to the Eu(Sr2) centre. PLE spectra of the Eu(Sr2) centre indeed contain features characteristic for the Eu(Sr1) one. Thus, the Eu(Sr1) → Eu(Sr2) energy transfer occurs also for the Sr2SiO4:0.1 mol% Eu β-phase, even though the Eu content is so low. The Eu(Sr2) centre may be exclusively excited in the 420–450 nm range of wavelengths (see Fig. 8c and d).
From Table 2 and the recorded crystallographic data, we know that orthorhombic Eu-activated Sr2SiO4 powders can be fabricated using either H3BO3 or SrCl2 flux, if the dopant content is not lower than 1 mol%. It is interesting to compare the luminescence spectra of two such compositions upon excitation at 255 nm. This is presented in Fig. 9a (samples SEu8 and SEu12). It is immediately evident that under such irradiation, the luminescence of the material made using the H3BO3 flux contained quite a significant admixture of the Eu3+ emission superimposed on the Eu2+ band. In the case of the powder synthesized with the help of the SrCl2 flux, the luminescence was generated by Eu2+ ions, exclusively. Thus, for some reason, H3BO3 hinders the susceptibility for chemical reduction of Eu3+ to the Eu2+ form. At this point, the reasons for that are not clear. Yet, in Fig. 9b (samples SEu8 and SEu12), which presents IR spectra of the orthorhombic versions of Sr2SiO4:Eu powders made with the help of both fluxes, we find information which seems to be useful in understanding this difference. Namely, in the case of the powder made using the H3BO3 flux, two well-resolved components are clearly seen in the 1150–1300 cm−1 range of wavenumbers. They can be identified as resulting from B–O stretching vibrations.36 Thus, boron enters the Sr2SiO4 host as an impurity. Since B3+ is a small ion (0.11 Å), it is expected to replace Si4+ (0.26 Å), as all other sites are occupied by greatly larger ions. If so, however, the smaller charge of B3+ compared to Si4+ may easily stabilize the Eu3+ ions (in the position of Sr2+)37 as then the electrostatic neutrality is maintained.
A similar comparison for the monoclinic structure could not be done, as with the Eu activator it could not be obtained as a pure phase. Thus, we can conclude that, compared to H3BO3, SrCl2 flux not only allows fabrication of powders with a better morphology, but also facilitates the reduction of Eu3+ to Eu2+. We should also note that the B–O vibrations are partially positioned at ∼1200 cm−1, which indicates that part of a boron impurity exists in BO3 groups in our composition.38,39 This may be induced by its much smaller size than Si, as mentioned above. BO3 groups, in contrary to BO4, were reported to not facilitate the reduction of europium.40 Some difficulty in efficient reduction of Eu to its 2+ state in silicates was also reported by Dobrowolska.41
Striking differences are observed between the orthorhombic and monoclinic Sr2SiO4:Ce materials in both the spectral distribution of the RL emissions and their efficiencies. The orthorhombic Sr2SiO4:Ce α′-phase (Fig. 10, blue line) gives only a weak emission upon excitation with X-rays, at the level of ∼10% of that of the commercial Lu2SiO5:Ce (LSO). Furthermore, the RL spectrum covers a much broader range of wavelengths (∼375–650 nm) than was seen in the PL spectra (see Fig. 5b and 6b). Upon optical excitation, the spectra of this phase were much narrower, which may imply that the inefficient RL results from both Ce and a defect/defects generated upon the impact of the high-energy X-rays. In contrast, the RL of the monoclinic Sr2SiO4:Ce β-phase (Fig. 10, red line) gives emission whose efficiency at least meets, if not surpasses, the yield of LSO. It cannot be excluded that the already impressive RL of the monoclinic Sr2SiO4:Ce might be further improved if dopant content and processing parameters are further optimized. This was beyond the scope of the present research, however. Since in the photoluminescence measurements such drastic differences in intensities of the emissions from the two phases were definitely not seen (though quantitative measurements were not performed), we may conclude that in the orthorhombic α′-phase, the efficiency of the host-to-activator energy transfer is critically lower than in the case of the monoclinic β-phase.42
Also the RL spectra of the Sr2SiO4:Eu presented in Fig. 11 surprise to some extent. In this case, Eu2+ gave quite significant RL from both phases. However, it appears that, in contrast with the PL spectra presented in Fig. 7b and d, in both polymorphs, only the Eu(Sr2) luminescent centre is active in the generation of light. It appears that the energy transfer from the host excited upon the impact of X-rays is preferentially transferred to the Eu2+ ions, giving the long-wavelength luminescent band peaking at around 580 nm in the orthorhombic phase and at around 540 nm in the monoclinic one (the 5–10 nm shift between peaks in the RL and PL spectra may result from the fact that the former spectra were not corrected for the system characteristics). The reason for such behaviour is not clear at present and its explanation would require rather extensive, specialized research. Yet a reasonable explanation/guess might be that the Eu(Sr2) ions giving the long-wavelength luminescence are more efficient hole traps compared to Eu(Sr1). Such a preferential trapping of holes by Eu(Sr2) would automatically make these ions more attractive for subsequent trapping of electrons from the conduction band, which would close the first step of harvesting the energy from the excited host by the emitting centres.43–45 Consequently, only the Eu(Sr2) centre would be fed by the energy acquired from the incident X-ray photons and only these ions would produce luminescent photons. A strongly preferential transfer of energy from a host to a dopant located in a specific symmetry site is a known effect. For example, in Lu2SiO5:Ce (LSO) scintillator crystals used in positron emitting tomography (PET) cameras, also, for lower concentrations, only one Ce site gives light upon the impact of γ-rays.46
A direct reason for that might be connected with the position of the ground states of Eu3+ ions occupying the two sites against the valence band, and thus the formal energy for h-trapping. From Fig. 7 and 8, we know that in both phases the long-wavelength emitting ions (Eu(Sr2)) have a lower energy of the first f–d transition. Accordingly, this can be taken as a measure of their (lower) energy for h-trapping. In other words, the holes from the valence band are energetically closer to the Eu(Sr2) ions. This may be the driving force for the preferential energy trapping in Eu(Sr2) seen in radioluminescence and described above. A similar effect was reported for storage/persistent phosphors containing two dopants acting as hole and electron traps. Depending on their relative positions against the valence (hole trap) and conduction (electron trap) bands, the energy upon releasing is emitted by only one of them.47
| This journal is © The Royal Society of Chemistry 2015 |